Common use of Board of Directors Compliance Obligations Clause in Contracts

Board of Directors Compliance Obligations. The Board of Directors (Board) shall remain responsible for the review and oversight of matters related to compliance with Federal health care program requirements and the obligations of this CIA. The Board shall, at a minimum, be responsible for the following: a. meeting at least quarterly to review and oversee LHC's Compliance Program, including but not limited to the performance of the Compliance Officer and Compliance Committee; b. ensuring that LHC adopts and implements policies, procedures, and practices designed to ensure compliance with the requirements set forth in this CIA and Federal health care program requirements; and c. for each Reporting Period of the CIA, adopting a resolution, signed by each member of the Board summarizing its review and oversight of LHC’s compliance with Federal health care program requirements and the obligations of this CIA. At minimum, the resolution shall include the following language: “The Board of Directors has made a reasonable inquiry into the operations of LHC’s Compliance Program including the performance of the Compliance Officer and the Compliance Committee. Based on its inquiry and review, the Board has concluded that, to the best of its knowledge, LHC has implemented an effective Compliance Program to meet Federal health care program requirements and the obligations of the CIA.” If the Board is unable to provide such a conclusion in the resolution, the Board shall include in the resolution a written explanation of the reasons why it is unable to provide the conclusion and the steps it is taking to implement an effective Compliance Program at LHC. LHC shall report to OIG, in writing, any changes in the composition of the Board, or any actions or changes that would affect the Board’s ability to perform the duties necessary to meet the obligations in this CIA, within 15 days after such a change.

Board of Directors Compliance Obligations. The Board of Directors (Board) shall remain be responsible for the review and oversight of matters related to compliance with Federal health care program requirements and the obligations of this CIA. The Board shall, at a minimum, be responsible for the following: a. meeting Meeting at least quarterly to review and oversee LHCPRMC's Compliance Program, including but not limited to the performance of the Compliance Officer and Compliance Committee; b. ensuring that LHC PRMC adopts and implements policies, procedures, and practices designed to ensure compliance with the requirements set forth in this CIA and Federal health care program requirements; and c. for each Reporting Period of the CIA, adopting a resolution, signed by each member of the Board summarizing its review and oversight of LHCPRMC’s compliance with Federal health care program requirements and the obligations of this CIA. At minimum, the resolution shall include the following language: “The Board of Directors has made a reasonable inquiry into the operations of LHCPRMC’s Compliance Program including the performance of the Compliance Officer and the Compliance Committee. Based on its inquiry and review, the Board has concluded that, to the best of its knowledge, LHC PRMC has implemented an effective Compliance Program to meet Federal health care program requirements and the obligations of the CIA.” If the Board is unable to provide such a conclusion in the resolution, the Board shall include in the resolution a written explanation of the reasons why it is unable to provide the conclusion and the steps it is taking to implement an effective Compliance Program at LHCPRMC. LHC PRMC shall report to OIG, in writing, any changes in the composition of the Board, or any actions or changes that would affect the Board’s ability to perform the duties necessary to meet the obligations in this CIA, within 15 days after such a change.